IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 114 filers reported holding IMMUNOVANT INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $182,692 | -11.9% | 11,779 | +0.8% | 0.02% | -26.5% |
| Q4 2022 | $207,480 | +205.1% | 11,689 | -4.1% | 0.03% | +240.0% |
| Q3 2022 | $68,000 | -87.1% | 12,195 | -91.0% | 0.01% | -78.3% |
| Q2 2022 | $527,000 | -29.3% | 135,228 | 0.0% | 0.05% | -28.1% |
| Q1 2022 | $745,000 | -19.9% | 135,228 | +23.9% | 0.06% | -9.9% |
| Q4 2021 | $930,000 | -35.1% | 109,138 | -19.6% | 0.07% | -25.3% |
| Q2 2021 | $1,434,000 | – | 135,700 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |